Gene · 926
Papers3,225
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,225
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4. | Int J Mol Sci | 2023 | 37894816 | PubTator, text mining | PubMed |
| TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors. | Biomedicines | 2023 | 37893178 | PubTator, text mining | PubMed |
| An NKG2A biased immune response confers protection for infection, autoimmune disease, and cancer. | Res Sq | 2023 | 37886475 | PubTator, text mining | PubMed |
| miR-7 is recruited to the high molecular weight RNA-induced silencing complex in CD8+ T cells upon activation and suppresses IL-2 signaling. | RNA | 2023 | 37879863 | PubTator, text mining | PubMed |
| Single-nucleus RNA sequencing reveals heterogenous microenvironments and specific drug response between cervical squamous cell carcinoma and adenocarcinoma. | EBioMedicine | 2023 | 37879219 | PubTator, text mining | PubMed |
| Host immunity associated with spontaneous suppression of viremia in therapy-naïve young rhesus macaques following neonatal SHIV infection. | J Virol | 2023 | 37874153 | PubTator, text mining | PubMed |
| Integrated analysis and validation of the TRIM28-H2AX-CDK4 diagnostic model assists to predict the progression of HCC. | Aging (Albany NY) | 2023 | 37870748 | PubTator, text mining | PubMed |
| [Identification of Peripheral Blood GZMK + CD8 + T Cells As Biomarkers of Alzheimer's Disease Based on Single-Cell Transcriptome]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2023 | 37866940 | PubTator, text mining | PubMed |
| A prognostic mathematical model based on tumor microenvironment-related genes expression for breast cancer patients. | Front Oncol | 2023 | 37860187 | PubTator, text mining | PubMed |
| Overexpression of SH2D1A promotes cancer progression and is associated with immune cell infiltration in hepatocellular carcinoma via bioinformatics and in vitro study. | BMC Cancer | 2023 | 37858067 | PubTator, text mining | PubMed |
| Paired yeast one-hybrid assays to detect DNA-binding cooperativity and antagonism across transcription factors. | Nat Commun | 2023 | 37853017 | PubTator, text mining | PubMed |
| Upregulation of BMP1 through ncRNAs correlates with adverse outcomes and immune infiltration in clear cell renal cell carcinoma. | Eur J Med Res | 2023 | 37848987 | PubTator, text mining | PubMed |
| Trimodal single-cell profiling reveals a novel pediatric CD8αα+ T cell subset and broad age-related molecular reprogramming across the T cell compartment. | Nat Immunol | 2023 | 37845489 | PubTator, text mining | PubMed |
| Integration of scRNA-Seq and bulk RNA-Seq uncover perturbed immune cell types and pathways of Kawasaki disease. | Front Immunol | 2023 | 37841239 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing of Donor-Reactive T Cells Reveals Role of Apoptosis in Donor-Specific Hyporesponsiveness of Kidney Transplant Recipients. | Int J Mol Sci | 2023 | 37833911 | PubTator, text mining | PubMed |
| Mini-TCRs: Truncated T cell receptors to generate T cells from induced pluripotent stem cells. | Mol Ther Methods Clin Dev | 2023 | 37822720 | PubTator, text mining | PubMed |
| A Case of Rare Dermatoarthropathy with Brief Review of Literature. | Indian J Dermatol | 2023 | 37822370 | PubTator, text mining | PubMed |
| Eukaryotic translation initiation factor 2α kinase 2 in pancreatic cancer: An approach towards managing clinical prognosis and molecular immunological characterization. | Oncol Lett | 2023 | 37818134 | PubTator, text mining | PubMed |
| Widespread and dynamic expression of granzyme C by skin-resident antiviral T cells. | Front Immunol | 2023 | 37809077 | PubTator, text mining | PubMed |
| Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients. | J Immunother Cancer | 2023 | 37802604 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/926/papers?page=13